Terlipressin Injection

Terlipressin 1 mg Injection
Life-Saving Vasopressor Support When Every Second Counts

Terlipressin 1 mg Injection is a synthetic vasopressin analogue indicated for emergency and critical care use. It provides potent vasoconstrictive action to manage life-threatening conditions like bleeding esophageal varices and hepatorenal syndrome (HRS). With proven hemodynamic stability and targeted splanchnic vasoconstriction, Terlipressin plays a vital role in advanced liver care and intensive settings.

First-Line Therapy for Bleeding Varices – Rapidly controls acute variceal hemorrhage and reduces portal pressure
Proven Efficacy in HRS – Enhances renal function and survival in hepatorenal syndrome (Type 1)
Powerful Yet Targeted – Selective vasoconstriction in the splanchnic circulation minimizes systemic effects
IV Ready – Formulated for intravenous use in critical care environments

Indications:

• Management of bleeding esophageal varices

• Treatment of hepatorenal syndrome (HRS Type 1)

• Adjunctive therapy in refractory septic shock (off-label in some regions)

Important Safety Information:
Use with caution in patients with cardiovascular disease, ischemic conditions, or respiratory disorders. Monitor blood pressure, electrolytes, and renal function closely during administration.